Meet the graphene pioneer taking the wonder material mainstream
Dr. Marco Caffio reveals how his team took on a seemingly impossible mission – to produce pristine, scalable, and reproducible graphene at a low cost
Dr. Marco Caffio reveals how his team took on a seemingly impossible mission – to produce pristine, scalable, and reproducible graphene at a low cost
The findings could lead to faster, more secure memory storage, in the form of antiferromagnetic bits
In this guest editorial, explore how artificial intelligence is becoming a powerful tool for drug discovery
In this on-demand webinar, we look at ways to improve time to result in critical pathways such as sepsis
Watch this on-demand webinar to gain an overview of recent technological advances in CRISPR/Cas gene editing
Scientific, technological and communications excellence has been celebrated at the Virtual Analytical Summit, with Eppendorf, Agilent and Thermo Fisher Scientific among those recognized
Watch world-leading scientists and industry experts online, February 23-24, to discover next-generation technologies to advance your research
Watch this on-demand webinar to learn more about emerging and cutting-edge techniques in NMR
Watch this on-demand webinar to discover how Brillouin microscopy and Raman spectroscopy can revolutionize your biophysical and biochemical analyses
Dr. Shuibing Chen discusses the advantages of organoids, surprising discoveries in COVID research and her hopes for revolutionizing the future of drug therapies
From Alzheimer’s disease to 3D brain modeling: Watch top speakers and connect with leading neuroscience innovators online, November 17-18
Explore our roundup of key considerations for a successful CRISPR/Cas9 experiment
We put your most pressing questions to the team behind Molecular Devices latest cellular imaging and analysis system to find out how it could make an impact in your lab
The first of Waters' new PREMIER class of liquid chromatography products
Grant received to use the Mission Bio Tapestri Platform to improve the measurement of residual cancerous cells remaining post-treatment
Simplexa™ GBS Direct molecular assay enables in vitro detection of Group B Streptococcus
Combination of ion channel and High Throughput Screening expertise to broaden drug discovery capability
Provides accurate low cell counts like never before